Award

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables

MEDICINES DISCOVERY CATAPULT

This public procurement record has 1 release in its history.

Award

16 Nov 2021 at 15:45

Award Notice
Summary of the contracting process

The Medicines Discovery Catapult Ltd., located in Cheshire, United Kingdom, has successfully completed the procurement process for the supply, delivery, and maintenance of an Illumina NextSeq 1000 Sequencing System and associated consumables. The procurement was conducted through a limited method, specifically negotiated without the publication of a contract notice, due to the technical specifications required for the workflow. The contract, valued at £300,000, was signed on 16th November 2021, following a 10-day standstill period that concluded on 26th November 2021.

This tender presents significant opportunities for businesses in the laboratory equipment industry, particularly those specializing in sequencing systems and related technical services. Companies that manufacture or distribute specialised laboratory equipment, as well as those offering installation, maintenance, and training services, would be well-suited to compete in similar future tenders. The unique technical requirements noted in this procurement process highlight the potential for businesses that can meet such specific demands to secure contracts with research and medical entities like the Medicines Discovery Catapult.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables

Notice Description

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables.

Lot Information

Lot 1

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables to the Medicines Discovery Catapult Ltd. The Illumina NextSeq 1000 Sequencing System is an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, primary analysis, and secondary analysis. The system includes embedded touchscreen monitor and on-instrument computer, control software, hardware accelerated analysis pipelines. The contract includes delivery, installation, maintenance and training. The associated consumables are also included in the scope of this contract.

Procurement Information

The Illumina sequencer for GeoMx is required by the Medicines Discovery Catapult Ltd (MDC) as it forms part of the GeoMx workflow for whole spatial transcriptome analysis. Illumina sequencer for GeoMx is required, there is no competition and competition is absent for technical reasons as the Illumina sequencer for GeoMx is the only instrument which has access to Illumina adapters within the nanostring reagents. Nanostring have developed a workflow with Illumina where Illumina's i5 and i7 sequences specifically add P5 and P7 sequences for binding to Illumina's flow cell. These sequences are part of the SeqCode that are for the library prep and there are no alternative sequences to obtain for analysis. Furthermore, the software offers a selection of Illumina sequencers to choose from when finalizing the readout group (to be able to start sequencing) - this will create files that are tailored towards use on the respective Illumina platforms. Most of all, the sequences (FASTQ files) need to be processed in order to be made compatible with the GeoMx for import. The pipeline software is tailored to work with the Illumina output files (including Illumina's index sequences) and cannot be used on sequences produced by any other system. Or you can directly process these files within Illumina's BaseSpace environment. The purchase of the equipment will enable a fully integrated workflow of the two systems. The MDC will follow a 10 day standstill period ending on midnight on Friday 26th November 2021. Following the successful completion of the standstill period the MDC will award the contract to Illumina Cambridge Ltd.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02f737
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/028616-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Negotiated without publication of a contract notice
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

38 - Laboratory, optical and precision equipments (excl. glasses)

CPV Codes

38000000 - Laboratory, optical and precision equipments (excl. glasses)

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£300,000 £100K-£500K

Notice Dates

Publication Date
16 Nov 20214 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
16 Nov 20214 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
MEDICINES DISCOVERY CATAPULT
Contact Name
Ms Laura Hough
Contact Email
laura.hough@md.catapult.org.uk
Contact Phone
+44 1625708394

Buyer Location

Locality
CHESHIRE
Postcode
SK10 4ZF
Post Town
Stockport
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD6 Cheshire
Small Region (ITL 3)
TLD62 Cheshire East
Delivery Location
TLD62 Cheshire East
Local Authority
Cheshire East
Electoral Ward
Chelford
Westminster Constituency
Tatton

Supplier Information

Number of Suppliers
1
Supplier Name

ILLUMINA CAMBRIDGE

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02f737-2021-11-16T15:45:33Z",
    "date": "2021-11-16T15:45:33Z",
    "ocid": "ocds-h6vhtk-02f737",
    "initiationType": "tender",
    "tender": {
        "id": "DN578493",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "38000000",
            "description": "Laboratory, optical and precision equipments (excl. glasses)"
        },
        "mainProcurementCategory": "goods",
        "description": "The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables.",
        "lots": [
            {
                "id": "1",
                "description": "The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables to the Medicines Discovery Catapult Ltd. The Illumina NextSeq 1000 Sequencing System is an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, primary analysis, and secondary analysis. The system includes embedded touchscreen monitor and on-instrument computer, control software, hardware accelerated analysis pipelines. The contract includes delivery, installation, maintenance and training. The associated consumables are also included in the scope of this contract.",
                "hasOptions": false
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKD62"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Negotiated without publication of a contract notice",
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_TECHNICAL",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons"
            }
        ],
        "procurementMethodRationale": "The Illumina sequencer for GeoMx is required by the Medicines Discovery Catapult Ltd (MDC) as it forms part of the GeoMx workflow for whole spatial transcriptome analysis. Illumina sequencer for GeoMx is required, there is no competition and competition is absent for technical reasons as the Illumina sequencer for GeoMx is the only instrument which has access to Illumina adapters within the nanostring reagents. Nanostring have developed a workflow with Illumina where Illumina's i5 and i7 sequences specifically add P5 and P7 sequences for binding to Illumina's flow cell. These sequences are part of the SeqCode that are for the library prep and there are no alternative sequences to obtain for analysis. Furthermore, the software offers a selection of Illumina sequencers to choose from when finalizing the readout group (to be able to start sequencing) - this will create files that are tailored towards use on the respective Illumina platforms. Most of all, the sequences (FASTQ files) need to be processed in order to be made compatible with the GeoMx for import. The pipeline software is tailored to work with the Illumina output files (including Illumina's index sequences) and cannot be used on sequences produced by any other system. Or you can directly process these files within Illumina's BaseSpace environment. The purchase of the equipment will enable a fully integrated workflow of the two systems. The MDC will follow a 10 day standstill period ending on midnight on Friday 26th November 2021. Following the successful completion of the standstill period the MDC will award the contract to Illumina Cambridge Ltd."
    },
    "awards": [
        {
            "id": "028616-2021-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-34764",
                    "name": "Illumina Cambridge Ltd"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-23690",
            "name": "Medicines Discovery Catapult",
            "identifier": {
                "legalName": "Medicines Discovery Catapult"
            },
            "address": {
                "streetAddress": "Block 35, Mereside, Alderley Park",
                "locality": "Cheshire",
                "region": "UKD62",
                "postalCode": "SK10 4ZF",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Ms Laura Hough",
                "telephone": "+44 1625708394",
                "email": "laura.hough@md.catapult.org.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://md.catapult.org.uk/",
                "buyerProfile": "https://md.catapult.org.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "description": "Research - Medical"
                    },
                    {
                        "scheme": "COFOG",
                        "description": "Research - Medical"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-34764",
            "name": "Illumina Cambridge Ltd",
            "identifier": {
                "legalName": "Illumina Cambridge Ltd"
            },
            "address": {
                "locality": "Essex",
                "region": "UKD62",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-26129",
            "name": "Medicines Discovery Catapult",
            "identifier": {
                "legalName": "Medicines Discovery Catapult"
            },
            "address": {
                "locality": "Alderley Edge",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-23690",
        "name": "Medicines Discovery Catapult"
    },
    "contracts": [
        {
            "id": "028616-2021-1",
            "awardID": "028616-2021-1",
            "status": "active",
            "value": {
                "amount": 300000,
                "currency": "GBP"
            },
            "dateSigned": "2021-11-16T00:00:00Z"
        }
    ],
    "language": "en"
}